Who Paid My Doc
M21-341 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Research payments
$4,187,486
Through program year 2025, $4,187,486 in research payments was reported against M21-341 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants, across 379 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $4,187,486 | 379 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Ramin Farsad Encinitas, CA Named on 18 payments
- Eugenio Angueira-Serrano Miami, FL Named on 16 payments
- Lowell Schmeltz Farmington Hills, MI Named on 12 payments
- Arvind Krishna Canton, OH Named on 10 payments
- Rodolfo Perez Gallardo Fort Myers, FL Named on 10 payments
- Madeline Jones Ryan Lincoln, NE Named on 8 payments
- Ajay Chaudhuri Buffalo, NY Named on 8 payments
- Cecil Farrington Salisbury, NC Named on 7 payments
- Miguel Trevino Clearwater, FL Named on 7 payments
- Ilja Hulinsky West Haven, CT Named on 7 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.